Theme: New and Emerging Target Therapies in Oncology

American Cancer Congress-2016

American Cancer Congress-2016

Conference Series LLC invites all the participants across the globe to attend the 15th World Congress on Cancer Therapy (American Cancer Congress 2016) on December 05-07, 2016 at Philadelphia, USA. 

American Cancer Congress 2016 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.

Why to attend???

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants .World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference.

Who Should Attend?

Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Post-Graduate students, Post-doctoral fellows, and Trainees.

Conference Series LLC provides an opportunistic environment and vibrant podium through these auspicious events to amplify these steps and meet the highest demand ever, by reflexive and cerebrative connections. Established in the year 2007, Conference Series has been progressively organizing scientific conferences across the globe, rendezvous which consist of various streams of scientific study to improve and accelerate discovery for a better tomorrow. The non-profit firm plans for organizing an average of 1000 international conferences per year which is supported by 700 open access journals and 80,000 Editorial Board Members. The number of reader views of the website has clocked 7.5 million and still counting. Lately around more than 1000 scientific associations of various fields from all over the world have shown interest in association with OMICS Group International to promote their research work. Conference Series conferences offer exciting features like international symposia, B2B meetings, trade shows, exhibitions, and international workshops to build global networking and meaningful academic research and industry alliances. Conference Series initiated the 'Young Scientist awards' to the enterprising young science researchers and scholars across the globe.

14th World Congress on Cancer Therapy (American Cancer 2016)

December 08-10, 2016 Dallas, USA

(Theme: Novel Approaches in Cancer Research & Therapy)

Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumors and neoplasms. Metastases are the major cause of death from cancer. Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012.

About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumour in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Why to attend???

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants .World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference.

Target Audience:

Researchers, Academicians, Physicians , Post Docs, Students , Pharmacy Industries, Academic scientists ,Industry professionals ,Diagnostic laboratory professionals.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date (977th Annual Conference)
December 05-07, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View